NZ328411A - Process for preparing an analog of a synthetic parathyroid hormone (pth) or a related peptide (pthrp) - Google Patents

Process for preparing an analog of a synthetic parathyroid hormone (pth) or a related peptide (pthrp)

Info

Publication number
NZ328411A
NZ328411A NZ328411A NZ32841197A NZ328411A NZ 328411 A NZ328411 A NZ 328411A NZ 328411 A NZ328411 A NZ 328411A NZ 32841197 A NZ32841197 A NZ 32841197A NZ 328411 A NZ328411 A NZ 328411A
Authority
NZ
New Zealand
Prior art keywords
pthrp
pth
analog
preparing
parathyroid hormone
Prior art date
Application number
NZ328411A
Other languages
English (en)
Inventor
Humberto Bartolome Arzeno
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ328411A publication Critical patent/NZ328411A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ328411A 1996-07-30 1997-07-24 Process for preparing an analog of a synthetic parathyroid hormone (pth) or a related peptide (pthrp) NZ328411A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2332296P 1996-07-30 1996-07-30

Publications (1)

Publication Number Publication Date
NZ328411A true NZ328411A (en) 1998-12-23

Family

ID=21814418

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ328411A NZ328411A (en) 1996-07-30 1997-07-24 Process for preparing an analog of a synthetic parathyroid hormone (pth) or a related peptide (pthrp)

Country Status (30)

Country Link
US (1) US6849710B1 (xx)
EP (1) EP0822200B1 (xx)
JP (1) JP4229992B2 (xx)
KR (1) KR100518982B1 (xx)
CN (1) CN1293096C (xx)
AR (2) AR008094A1 (xx)
AT (1) ATE277080T1 (xx)
AU (1) AU731160B2 (xx)
BR (1) BR9704138A (xx)
CA (1) CA2206008C (xx)
CO (1) CO4650046A1 (xx)
CZ (1) CZ239697A3 (xx)
DE (1) DE69730787T2 (xx)
DK (1) DK0822200T3 (xx)
ES (1) ES2227639T3 (xx)
HR (1) HRP970416A2 (xx)
HU (1) HUP9701277A3 (xx)
IL (1) IL121391A0 (xx)
MA (1) MA24353A1 (xx)
MX (1) MX9705719A (xx)
NO (1) NO973482L (xx)
NZ (1) NZ328411A (xx)
PE (1) PE91998A1 (xx)
PL (1) PL321391A1 (xx)
SG (1) SG67408A1 (xx)
TR (1) TR199700714A2 (xx)
TW (1) TW505654B (xx)
UY (1) UY24651A1 (xx)
YU (1) YU32197A (xx)
ZA (1) ZA976555B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7015195B2 (en) * 2002-01-10 2006-03-21 Osteotrophin, Llc Treatment of bone disorders with skeletal anabolic drugs
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
CA2628945A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
DK1979370T3 (da) * 2006-01-17 2010-06-28 Organon Nv Selektiv enzymatisk hydrolyse af C-terminale tert-butyl-ester peptider
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
DK2957278T3 (en) 2006-10-03 2017-07-31 Radius Health Inc STABLE COMPOSITION COMPREHENSIVE PTHRP AND APPLICATIONS THEREOF
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
US10087221B2 (en) 2013-03-21 2018-10-02 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
CN104530198B (zh) * 2014-12-09 2017-09-15 兰州大学 一种片段缩合制备醋酸去氨加压素的方法
RU2737496C2 (ru) 2015-04-29 2020-12-01 Радиус Фармасьютикалз, Инк. Способы лечения рака
FI3565542T3 (fi) 2017-01-05 2024-06-24 Radius Pharmaceuticals Inc Rad1901-2hcl:n polymorfisia muotoja
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
EP3765488A1 (en) * 2018-03-12 2021-01-20 Fresenius Kabi iPSUM S.r.l. Process for the manufacture of pthrp analogue
US11643385B2 (en) 2018-07-04 2023-05-09 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD1901-2HCl
CN111057139B (zh) * 2018-10-17 2023-12-22 南京华威医药科技集团有限公司 一种制备特立帕肽的新工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
JPH05509098A (ja) * 1990-07-13 1993-12-16 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア 3,6または9位において変性されている副甲状腺ホルモン類似体
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN

Also Published As

Publication number Publication date
KR100518982B1 (ko) 2006-05-29
AR008094A1 (es) 1999-12-09
HU9701277D0 (en) 1997-09-29
KR980009282A (ko) 1998-04-30
AU3236297A (en) 1998-02-05
DK0822200T3 (da) 2005-01-31
CA2206008C (en) 2008-09-23
PE91998A1 (es) 1998-12-31
IL121391A0 (en) 1998-01-04
JPH1077295A (ja) 1998-03-24
JP4229992B2 (ja) 2009-02-25
AR016981A2 (es) 2001-08-01
SG67408A1 (en) 1999-09-21
HUP9701277A2 (hu) 1998-11-30
DE69730787T2 (de) 2005-10-13
HRP970416A2 (en) 1998-08-31
CZ239697A3 (cs) 1998-04-15
TR199700714A2 (xx) 1998-02-21
CN1293096C (zh) 2007-01-03
EP0822200B1 (en) 2004-09-22
ATE277080T1 (de) 2004-10-15
CO4650046A1 (es) 1998-09-03
CN1174845A (zh) 1998-03-04
EP0822200A1 (en) 1998-02-04
UY24651A1 (es) 2000-12-29
MA24353A1 (fr) 1998-07-01
ES2227639T3 (es) 2005-04-01
US6849710B1 (en) 2005-02-01
HUP9701277A3 (en) 2001-02-28
PL321391A1 (en) 1998-02-02
MX9705719A (es) 1998-02-28
CA2206008A1 (en) 1998-01-30
NO973482L (no) 1998-02-02
DE69730787D1 (de) 2004-10-28
YU32197A (sh) 1999-07-28
AU731160B2 (en) 2001-03-22
NO973482D0 (no) 1997-07-29
TW505654B (en) 2002-10-11
ZA976555B (en) 1998-01-30
BR9704138A (pt) 1998-12-29

Similar Documents

Publication Publication Date Title
NZ328411A (en) Process for preparing an analog of a synthetic parathyroid hormone (pth) or a related peptide (pthrp)
HUP9901718A3 (en) Analogs of parathyroid hormone
KR20010012568A (ko) 펩타이드 부갑상선 호르몬 유사체 및 이를 포함하는 약제학적 조성물
LT99010A (en) Parathyroid hormone analogues for the treatment of osteoporosis
GB2234169B (en) A method for preparing a sustained-release pharmaceutical peptide composition
HUP9904596A3 (en) Analogs of parathyroid hormone
ZA94679B (en) Benzo-fused lactams promote release of growth hormone.
EP0669830A4 (en) SUBSTITUTED DIPEPTIDE ANALOGS PROMOTING THE RELEASE OF GROWTH HORMONE.
AU1447600A (en) Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
IL116743A0 (en) Pharmaceutical composition comprising a growth hormone
IL154115A0 (en) Process for the preparation of growth hormone secretagogues
HUP0105460A3 (en) Hemiasterlin analogs and process for preparation thereof
HUP9902095A3 (en) New process for the preparation of a growth hormone secretagogue
ZA98438B (en) A method for stabilizing a peptide and a freese-dried pharmaceutical composition comprising a peptide stabilized by the said method
GB2283252B (en) A method for sewing circumferentially the edges of uphlostery ensembles
AU4993497A (en) Convergent process for the preparation of a growth hormone secretagogue
ZA959161B (en) Process for recovering a substance or substance group from a mixture
EP0663834A4 (en) GROWTH HORMONE RELEASING PEPTIDES.
EP0779813A4 (en) PHOSPHONATES AND PARATHORMONE AGAINST OSTEOPOROSIS
IL116742A0 (en) Pharmaceutical composition comprising a growth hormone
GR900100164A (en) Method for preparating sdk peptides
IL116741A0 (en) Pharmaceutical composition comprising a growth hormone
GB9602949D0 (en) Process for the preparation of a growth hormone secretagogue
HK1017894A1 (en) Polymorphic forms of a growth hormone secretagogue
GB9219068D0 (en) New polypeptide compound and a process for preparation thereof

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)